A Prospective, Observational, Open-Label, Non-Randomized, Single Dose, Single centre, Two way, Parallel group, Bioequivalence Study of Two Formulations of Pemetrexed in Indian Adult Chemo-Naive, Adenocarcinoma NSCLC Patients.

Trial Profile

A Prospective, Observational, Open-Label, Non-Randomized, Single Dose, Single centre, Two way, Parallel group, Bioequivalence Study of Two Formulations of Pemetrexed in Indian Adult Chemo-Naive, Adenocarcinoma NSCLC Patients.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Pemetrexed (Primary)
  • Indications Adenocarcinoma; Non-small cell lung cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 03 Oct 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top